113 related articles for article (PubMed ID: 35121522)
21. Isolated pulmonary recurrence after resection of pancreatic cancer: the effect of patient factors and treatment modalities on survival.
Groot VP; Blair AB; Gemenetzis G; Ding D; Burkhart RA; van Oosten AF; Molenaar IQ; Cameron JL; Weiss MJ; Yang SC; Wolfgang CL; He J
HPB (Oxford); 2019 Aug; 21(8):998-1008. PubMed ID: 30777697
[TBL] [Abstract][Full Text] [Related]
22. Do patients with metastatic pancreatic adenocarcinoma to the lung have improved survival?
Ebrahimi A; Cham J; Puglisi L; De Shadarevian M; Hermel DJ; Spierling Bagsic SR; Sigal D
Cancer Med; 2023 May; 12(9):10243-10253. PubMed ID: 36916531
[TBL] [Abstract][Full Text] [Related]
23. Surgical Treatment for Pulmonary Metastasis of Pancreatic Ductal Adenocarcinoma: Study of 12 Cases.
Yasukawa M; Kawaguchi T; Kawai N; Tojo T; Taniguchi S
Anticancer Res; 2017 Oct; 37(10):5573-5576. PubMed ID: 28982872
[TBL] [Abstract][Full Text] [Related]
24. Heterogeneity of metastatic pancreatic adenocarcinoma: Lung metastasis show better prognosis than liver metastasis-a case control study.
Decoster C; Gilabert M; Autret A; Turrini O; Oziel-Taieb S; Poizat F; Giovannini M; Viens P; Iovanna J; Raoul JL
Oncotarget; 2016 Jul; 7(29):45649-45655. PubMed ID: 27286454
[TBL] [Abstract][Full Text] [Related]
25. [Expression of B cell transposition gene 3 in pancreatic ductal adenocarcinoma and its prognostic value].
Chen J; Zhou ZC; Liu WB; Wang J; Chen XJ; Shen YY; Zhong ZX
Zhonghua Wai Ke Za Zhi; 2017 Nov; 55(11):863-867. PubMed ID: 29136736
[No Abstract] [Full Text] [Related]
26. Survival Impact of Pulmonary Metastasis as Recurrence of Pancreatic Ductal Adenocarcinoma.
Yamashita K; Miyamoto A; Hama N; Asaoka T; Maeda S; Omiya H; Takami K; Doki Y; Mori M; Nakamori S
Dig Surg; 2015; 32(6):464-71. PubMed ID: 26517228
[TBL] [Abstract][Full Text] [Related]
27. Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy.
Li R; He Y; Zhang H; Wang J; Liu X; Liu H; Wu H; Liang Z
Front Immunol; 2021; 12():690056. PubMed ID: 34335594
[TBL] [Abstract][Full Text] [Related]
28. Biomarker panel predicts survival after resection in pancreatic ductal adenocarcinoma: A multi-institutional cohort study.
Nahm CB; Turchini J; Jamieson N; Moon E; Sioson L; Itchins M; Arena J; Colvin E; Howell VM; Pavlakis N; Clarke S; Samra JS; Gill AJ; Mittal A
Eur J Surg Oncol; 2019 Feb; 45(2):218-224. PubMed ID: 30348604
[TBL] [Abstract][Full Text] [Related]
29. MiR-10b inhibits migration and invasion of pancreatic ductal adenocarcinoma via regulating E2F7.
Xu C; Qi X
J Clin Lab Anal; 2020 Oct; 34(10):e23442. PubMed ID: 32592206
[TBL] [Abstract][Full Text] [Related]
30. Gene expression analysis of embryonic pancreas development master regulators and terminal cell fate markers in resected pancreatic cancer: A correlation with clinical outcome.
Dugnani E; Sordi V; Pellegrini S; Chimienti R; Marzinotto I; Pasquale V; Liberati D; Balzano G; Doglioni C; Reni M; Gandolfi A; Falconi M; Lampasona V; Piemonti L
Pancreatology; 2018 Dec; 18(8):945-953. PubMed ID: 30293872
[TBL] [Abstract][Full Text] [Related]
31. Proposal for a definition of "Oligometastatic disease in pancreatic cancer".
Damanakis AI; Ostertag L; Waldschmidt D; Kütting F; Quaas A; Plum P; Bruns CJ; Gebauer F; Popp F
BMC Cancer; 2019 Dec; 19(1):1261. PubMed ID: 31888547
[TBL] [Abstract][Full Text] [Related]
32. Infiltrating immune cells and gene mutations in pancreatic ductal adenocarcinoma.
Wang WQ; Liu L; Xu HX; Wu CT; Xiang JF; Xu J; Liu C; Long J; Ni QX; Yu XJ
Br J Surg; 2016 Aug; 103(9):1189-99. PubMed ID: 27256393
[TBL] [Abstract][Full Text] [Related]
33. Ovarian Metastasis from Pancreatic Ductal Adenocarcinoma.
Habib JR; Pasha S; Khan S; Kinny-Köster B; Shoucair S; Thompson ED; Yu J; Lafaro K; Burkhart RA; Burns WR; Ronnett BM; Wolfgang CL; Hruban RH; He J; Fishman EK; Javed AA
World J Surg; 2021 Oct; 45(10):3157-3164. PubMed ID: 34236477
[TBL] [Abstract][Full Text] [Related]
34. Association between primary origin (head, body and tail) of metastasised pancreatic ductal adenocarcinoma and oncologic outcome: A population-based analysis.
Mackay TM; van Erning FN; van der Geest LGM; de Groot JWB; Haj Mohammad N; Lemmens VE; van Laarhoven HW; Besselink MG; Wilmink JW;
Eur J Cancer; 2019 Jan; 106():99-105. PubMed ID: 30476732
[TBL] [Abstract][Full Text] [Related]
35. A single center experience in resectable pancreatic ductal adenocarcinoma : the limitations of the surgery-first approach. Critical review of the literature and proposals for practice update.
Dumont R; Puleo F; Collignon J; Meurisse N; Chavez M; Seidel L; Gast P; Polus M; Loly C; Delvenne P; Meunier P; Hustinx R; Deroover A; Detry O; Louis E; Martinive P; Van Daele D
Acta Gastroenterol Belg; 2017; 80(4):451-461. PubMed ID: 29560639
[TBL] [Abstract][Full Text] [Related]
36. Transcriptome profiling reveals liver metastasis-associated genes in pancreatic ductal adenocarcinoma.
Yu Y; Wang Z; Mo DH; Wang Z; Li G
Math Biosci Eng; 2021 Feb; 18(2):1708-1721. PubMed ID: 33757206
[TBL] [Abstract][Full Text] [Related]
37. Local treatment of pancreatic cancer metastases: A multicenter French study of the AGEO group.
Breton C; Meyer A; Malka D; Matias M; De Baere T; Hammel P; Sa Cunha A; Lucchese A; Fuks D; Coriat R; Gallois C; Touchefeu Y; Maillet M; Trouilloud I; Rompteaux P; Carbonnel F; Soularue E
Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101607. PubMed ID: 33662776
[TBL] [Abstract][Full Text] [Related]
38. Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes.
Zhao L; Zhao H; Yan H
BMC Cancer; 2018 May; 18(1):603. PubMed ID: 29843660
[TBL] [Abstract][Full Text] [Related]
39. Subtype-Discordant Pancreatic Ductal Adenocarcinoma Tumors Show Intermediate Clinical and Molecular Characteristics.
Topham JT; Karasinska JM; Lee MKC; Csizmok V; Williamson LM; Jang GH; Denroche RE; Tsang ES; Kalloger SE; Wong HL; O'Kane GM; Moore RA; Mungall AJ; Notta F; Loree JM; Wilson JM; Bathe O; Tang PA; Goodwin R; Knox JJ; Gallinger S; Laskin J; Marra MA; Jones SJM; Renouf DJ; Schaeffer DF
Clin Cancer Res; 2021 Jan; 27(1):150-157. PubMed ID: 33051307
[TBL] [Abstract][Full Text] [Related]
40. Percutaneous Radiofrequency Ablation for Metachronous Hepatic Metastases after Curative Resection of Pancreatic Adenocarcinoma.
Lee SJ; Kim JH; Kim SY; Won HJ; Shin YM; Kim PN
Korean J Radiol; 2020 Mar; 21(3):316-324. PubMed ID: 32090524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
